File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: New Insights in Symptom Assessment: The Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS)

TitleNew Insights in Symptom Assessment: The Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS)
Authors
Issue Date2008
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpainsymman
Citation
Journal Of Pain And Symptom Management, 2008, v. 36 n. 6, p. 584-595 How to Cite?
AbstractThere are very few symptom assessment instruments in Chinese. We present the validity and reliability of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed Form MSAS (CMSAS) in Chinese cancer patients. The Chinese version of the 32-item MSAS-SF, a self-report measure for assessing symptom distress and frequency in cancer patients, was administered to 256 Chinese patients with colorectal cancer at a clinical oncology outpatient unit. Highly prevalent symptoms included worrying (59%), dry mouth (54%), lack of energy (54%), feeling sad (48%), feeling irritable (48%), and pain (41%). Both the MSAS-SF and CMSAS demonstrated good validity and reliability. For the MSAS-SF subscales, Cronbach alphas ranged from 0.84 to 0.91, and for CMSAS subscales, from 0.79 to 0.87. Moderate-to-high correlations of MSAS-SF and CMSAS subscales with appropriate European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 subscales (0.42-0.71, Ps < 0.001) indicated acceptable convergent validity. Low correlations with the Rosenberg Self-Esteem and Optimism Scale (0.22, P < 0.001) indicated divergent validity. MSAS subscales varied as expected with other Chinese scales-the Chinese Health Questionnaire (CHQ) and the Life Orientation Scale. Construct validity of both MSAS versions was demonstrated by effective differentiation between clinically distinct patient groups (Karnofsky scores <80% vs. ≥80% [P < 0.001]; no active treatment vs. active treatment [P < 0.002-0.034]; CHQ-12 scores ≤4 vs. CHQ-12 scores >4 [P < 0.001]). The Number of Symptoms subscale correlated appropriately with the EORTC QLQ-C30 function (-0.46 to -0.60, P < 0.001) and symptom scales (0.31-0.64, P < 0.001). The average time to complete the MSAS-SF was six minutes. The Chinese versions of the MSAS-SF and CMSAS are valid and practical measures. Further validation is needed for Chinese patients with other cancer types and with other symptom instruments. © 2008.
Persistent Identifierhttp://hdl.handle.net/10722/60327
ISSN
2015 Impact Factor: 2.649
2015 SCImago Journal Rankings: 1.514
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLam, WWTen_HK
dc.contributor.authorLaw, CCen_HK
dc.contributor.authorFu, YTen_HK
dc.contributor.authorWong, KHen_HK
dc.contributor.authorChang, VTen_HK
dc.contributor.authorFielding, Ren_HK
dc.date.accessioned2010-05-31T04:08:21Z-
dc.date.available2010-05-31T04:08:21Z-
dc.date.issued2008en_HK
dc.identifier.citationJournal Of Pain And Symptom Management, 2008, v. 36 n. 6, p. 584-595en_HK
dc.identifier.issn0885-3924en_HK
dc.identifier.urihttp://hdl.handle.net/10722/60327-
dc.description.abstractThere are very few symptom assessment instruments in Chinese. We present the validity and reliability of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed Form MSAS (CMSAS) in Chinese cancer patients. The Chinese version of the 32-item MSAS-SF, a self-report measure for assessing symptom distress and frequency in cancer patients, was administered to 256 Chinese patients with colorectal cancer at a clinical oncology outpatient unit. Highly prevalent symptoms included worrying (59%), dry mouth (54%), lack of energy (54%), feeling sad (48%), feeling irritable (48%), and pain (41%). Both the MSAS-SF and CMSAS demonstrated good validity and reliability. For the MSAS-SF subscales, Cronbach alphas ranged from 0.84 to 0.91, and for CMSAS subscales, from 0.79 to 0.87. Moderate-to-high correlations of MSAS-SF and CMSAS subscales with appropriate European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 subscales (0.42-0.71, Ps < 0.001) indicated acceptable convergent validity. Low correlations with the Rosenberg Self-Esteem and Optimism Scale (0.22, P < 0.001) indicated divergent validity. MSAS subscales varied as expected with other Chinese scales-the Chinese Health Questionnaire (CHQ) and the Life Orientation Scale. Construct validity of both MSAS versions was demonstrated by effective differentiation between clinically distinct patient groups (Karnofsky scores <80% vs. ≥80% [P < 0.001]; no active treatment vs. active treatment [P < 0.002-0.034]; CHQ-12 scores ≤4 vs. CHQ-12 scores >4 [P < 0.001]). The Number of Symptoms subscale correlated appropriately with the EORTC QLQ-C30 function (-0.46 to -0.60, P < 0.001) and symptom scales (0.31-0.64, P < 0.001). The average time to complete the MSAS-SF was six minutes. The Chinese versions of the MSAS-SF and CMSAS are valid and practical measures. Further validation is needed for Chinese patients with other cancer types and with other symptom instruments. © 2008.en_HK
dc.languageengen_HK
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpainsymmanen_HK
dc.relation.ispartofJournal of Pain and Symptom Managementen_HK
dc.rightsJournal of Pain and Symptom Management. Copyright © Elsevier Inc.en_HK
dc.subject.meshAdulten_HK
dc.subject.meshAgeden_HK
dc.subject.meshChina - epidemiologyen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHealth Status Indicatorsen_HK
dc.subject.meshHumansen_HK
dc.subject.meshMaleen_HK
dc.subject.meshMiddle Ageden_HK
dc.subject.meshNeoplasms - complications - diagnosis - epidemiologyen_HK
dc.subject.meshPain - complications - diagnosis - epidemiologyen_HK
dc.subject.meshPain Measurement - methods - statistics & numerical dataen_HK
dc.subject.meshPrevalenceen_HK
dc.subject.meshQuestionnairesen_HK
dc.subject.meshReproducibility of Resultsen_HK
dc.subject.meshSensitivity and Specificityen_HK
dc.titleNew Insights in Symptom Assessment: The Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS)en_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0885-3924&volume=36&issue=6&spage=584&epage=595&date=2008&atitle=New+Insights+in+Symptom+Assessment:+The+Chinese+Versions+of+the+Memorial+Symptom+Assessment+Scale+Short+Form+(MSAS-SF)+and+the+Condensed+MSAS+(CMSAS)en_HK
dc.identifier.emailLam, WWT:wwtlam@hku.hken_HK
dc.identifier.emailFielding, R:fielding@hku.hken_HK
dc.identifier.authorityLam, WWT=rp00443en_HK
dc.identifier.authorityFielding, R=rp00339en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jpainsymman.2007.12.008en_HK
dc.identifier.pmid18434076-
dc.identifier.scopuseid_2-s2.0-57049174641en_HK
dc.identifier.hkuros153958en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-57049174641&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume36en_HK
dc.identifier.issue6en_HK
dc.identifier.spage584en_HK
dc.identifier.epage595en_HK
dc.identifier.isiWOS:000262023500003-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridLam, WWT=7203022022en_HK
dc.identifier.scopusauthoridLaw, CC=23091606600en_HK
dc.identifier.scopusauthoridFu, YT=7404433569en_HK
dc.identifier.scopusauthoridWong, KH=7404760106en_HK
dc.identifier.scopusauthoridChang, VT=7101604365en_HK
dc.identifier.scopusauthoridFielding, R=7102200484en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats